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Environmental stress and its interaction with genetic variation are key contributors in the
development of depression and anxiety, yet there is a failure to identify replicable genetic
variants and gene-interaction effects in the background of these psychiatric symptoms.
Recently it has been reported that 5-HTTLPR and NOSI interact with financial but
not other types of recent stressors in the development of depression. In the present
study we investigated the interaction of GABRA6 rs3219151 and CNR1 rs7766029
in interaction with different types of recent life events on the presence of depression
and anxiety in a large general population sample. 2191 participants completed the
List of Threatening Experiences questionnaire which covers four categories of stressful
life events (financial problems, illness/personal problems, intimate relationships, and
social network) experienced over the previous year and the Brief Symptom Inventory
for depression and anxiety symptoms. Participants were genotyped for rs3219151 and
rs7766029. Data were analyzed with linear regression models with age and gender as
covariates. Results indicated that CNR1 rs7766029 interacted significantly with financial
but not other types of life events both in case of depression and anxiety symptoms.
In contrast, GABRA6 rs3219151 showed a significant interaction with social network
related life events in case of anxiety and with illness/personal problem-related life events
in case of depression. Our results suggest that the psychological impact of different
types of recent stress may be differentially modulated by distinct molecular genetic
pathways. Furthermore, in case of certain genetic variants, the occurring psychiatric
symptom may depend on the type of stress experienced.
Keywords: types of stress, depression, anxiety, gene-environment interaction, GABA, GABRA6, CNR1,
endocannabinoid system
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INTRODUCTION
In spite of the ever-increasing interest in genetic mechanisms of
depression, findings in candidate gene association studies have
generally not been replicated and not detected in genome-wide
association studies (Flint and Kendler, 2014; Dunn et al., 2015;
Gonda et al., 2018c). Recently, a study investigating variation in
7 genes in pathways previously implicated in the neurobiology
of depression found that none influenced depressive phenotype
in the absence of exposure to recent stress (Gonda et al., 2018b).
However, in those exposed to moderate and/or severe stress, the
majority of variants showed “relevance,” a Bayesian measure, to
phenotype. In some genes relevance was greatest for moderate
rather than severe stress suggesting that may recruit different
or additional genes and/or neurotransmitter systems. The 5-
HTTLPR polymorphism is the most widely studied candidate
mechanism of depression with the most contradictory findings in
individual (Juhasz et al., 2015) and meta-analytic studies (Bleys
et al., 2018; Culverhouse et al., 2018a,b), We recently reported
that the polymorphism did not modify risk of depression either
alone or in interaction with a unitary measure of life events
(Gonda et al., 2016a,b, 2018a). However, the short allele of 5-
HTTLPR was associated with increased depressive symptoms
in those exposed to recent financial stressors, but not in those
exposed to any other types of recent life events. Furthermore,
in those aged 30 or younger the short allele showed an
inverse impact on depression when exposed to social stress,
reflecting a possible protective effect of this variant. These results
suggest that the effect of the majority of genes involved in
depression may be manifested only under certain environmental
settings, and different types of stressors can exert their effects
via divergent genetic and ultimately neurochemical pathways.
Consequentially, different types of stressors should be analyzed
separately in gene-environment interaction studies of depression.
Our currently used antidepressants (Gonda et al., 2018c),
all of which – with the current exception of agomelatine
and the possible exception of esketamine – act primarily
on monoaminergic systems show only a frustratingly limited
clinical efficacy. Therefore it is crucial to understand the
involvement of other genes and neurochemical systems, and
especially in interaction with possibly pro-depressive stress in the
background of depression.
Recently, we reported that a variation of the GABRA6 gene
encoding the alpha6 subunit of the GABA-A receptor has
no main effect on depression but exerts a significant impact
following exposure to recent stress on several depression- and
anxiety-related symptoms, giving rise to a symptom constellation
that significantly increases suicide risk (Gonda et al., 2017).
In this study the different types of recent life stressors were
not studied separately, nevertheless, according to previous
studies recent social stress may be mediated by the GABRA6
gene (Uhart et al., 2004). Another system involved both in
stress and in depression and anxiety, is the endocannabinoid
system, with its relevance underlined by the withdrawal of
the endocannabionoid-1 receptor antagonist rimonabant from
the market due to severe psychological side effects including
increased anxiety and depression (Christensen et al., 2008). While
previously a significant interaction effect between stress and
CNR1 receptor variation on depressive symptoms (Juhasz et al.,
2009) has been reported, and an effect of CNR1 receptor variants
on anxiety influenced also by serotonin receptor variants have
been described (Lazary et al., 2009, 2011) the role of different
stress types in this interaction has not been studied. Thus, the aim
of the present study was to investigate the effect of the interaction
between different types of recent life events and GABRA6 or
CNR1 gene variants on recent depressive/anxiety symptoms in a
large European general population sample.
MATERIALS AND METHODS
Study Population
Under the aegis of the NewMood study (New Molecules
in Mood Disorders, LHSM-CT-2004-503474, Sixth Framework
Program of the European Union) (Deakin et al., 2011),
adult subjects were recruited from the general population
through advertisements, a website and general practices. 2269
subjects (923 in Budapest, Hungary, and 1346 in Manchester,
United Kingdom) provided self-reported data on gender, age,
recent stress, current depression, and anxiety scores by filling
out a questionnaire pack, and provided genetic data by a saliva
sampling kit. All of them reported to be of European white
ethnic origin, and none of them reported to have any relative
participating in the study.
All of the participants signed the official informed
consent form. The study was carried out in accordance
with the Declaration of Helsinki, and it was approved
both by the Scientific and Research Ethics Committee of
the Medical Research Council, Budapest, Hungary, and by
the North Manchester Local Research Ethics Committee,
Manchester, United Kingdom.
Among these participants, 2193 (n = 902 in Budapest, and
n = 1291 in Manchester) were successfully genotyped for CNR1
rs7766029, and n = 2206 (n = 902 in Budapest, and n = 1304 in
Manchester) for GABRA6 rs3219151.
Phenotypes
The Brief Symptom Inventory (BSI) was used to measure current
levels of anxiety and depression experienced within the past
7 days (Derogatis, 1993). Each depression and anxiety item was
scored 0–4 depending on the distress caused. Anxiety score was
calculated as the sum of anxiety symptom item scores divided
by the number of completed items, and depression score was
calculated as the sum of depression and additional item scores
divided by the number of completed items.
Four different types of recent stress were measured by
the List of Threatening Experiences (Brugha et al., 1985),
summing the number of recent negative life events (RLEs)
pertaining to each subscale, occurring within the last year.
These subscales have already been used in gene-by-environment
(GxE) interaction models in our previous genetic association
analyses (Gonda et al., 2016a). The RLE-relationship subscale
encompasses problems in marriage or steady relationship (e.g.,
“separation due to marital problems” and “broke off steady
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relationship”). The RLE-financial subscale denotes for financial
crisis, becoming unemployed or unsuccessfully seeking work
(e.g., “became unemployed or seeking work for more than
1 month” and “major financial crisis”). The RLE-illness/personal
problems subscale embodies illness, injury, assault, problems
with the police, a relative, a close friend or neighbor, court
appearance, and losing or being stolen something (“serious
illness,” “injury,” or “assault to self ” and “serious problems with
close friend,” “neighbor,” or “relative”). Finally, the RLE-social
(social network disturbances) subscale comprises items on death,
illness, injury or assault of a relative or friend (“close friend” or
“other relative died” and “serious illness,” “injury,” or “assault to
close relative”). Intercorrelations between the four subscales have
been reported in Gonda et al. (2016a).
Genotypes
Participants provided buccal mucosa cells collected by a
cytology brush (Cytobrush plus C0012, Durbin PLC). Genomic
DNA was extracted according to the protocol of Freeman
et al. (2003). Genotyping was performed by the Sequenom’s
MassARRAY technology (1San Diego, CA, United States) with
the IplexTM assay. All laboratory work, carried out under the
ISO 9001:2000 quality management requirements, was blinded
regarding phenotypes.
Statistical Analyses
IBM SPSS Statistics 21 was used to calculate descriptive statistics
on the variables and their comparisons between the Budapest and
Manchester subsamples, in addition, to run univariate general
linear models for visualization purposes.
Plink v1.902 was used to calculate Hardy-Weinberg
equilibrium and minor allele frequency (MAF), and to
build additive linear regression models on BSI anxiety and
depression scores as primary and secondary analyses, and
on each RLE subscale to test gene-environment correlation.
Analyses were supported by scripts individually written in R
3.0.2 (R Core Team, 2013).
In the linear regression models run either in Plink or in SPSS,
gender and age were always covariates. In case of the combined
Budapest + Manchester sample, population was an additional
covariate. In case of the GxE models on the BSI scores, main
effects of both G and E were also included as covariates.
Only in order to facilitate visualization in the general linear
models, RLE scores were divided into three categories as
described previously (Gonda et al., 2016a): 0 event, 1 event,
2 or more events.
P-values of the primary tests were entered into QVALUE
v1.0 (Storey et al., 2004) to calculate false discovery rate (FDR)
q-values (without robust method), with the aim of correction
for multiple testing. To estimate the proportion of true null
hypotheses, tuning parameter lambda was set to be from 0 to
0.99 by 0.05, and a bootstrap method was used for automatically
choosing lambda. In case of the primary tests, we consider results
with a q-value ≤ 0.05 as significant.
1www.sequenom.com
2https://www.cog-genomics.org/plink2
In case of secondary tests and all descriptive statistics,
we consider a p-value ≤ 0.05 as significant, and a
p-value ≤ 0.10 as trend.
To evaluate statistical power of the primary tests, Quanto
v1.23 was used. Type I error rate was set to 0.05, and we
assumed an RGE2 = 0.5% for the GxE term, an RG2 = 0% for
the G term, and RE2 values, based on Pearson correlations and
coefficients of determination (n = 2269), as the following. On
BSI anxiety score, RLE-relationship has an RE2 of 0.0146, RLE-
financial has an RE2 of 0.0562, RLE-illness/personal problems
has an RE2 of 0.0324, and RLE-social has an insignificant
RE2 of 0.0005. On BSI depression score, RLE-relationship has
an RE2 of 0.0272, RLE-financial has an RE2 of 0.0655, RLE-
illness/personal problems has an RE2 of 0.0396, and RLE-social
has an insignificant RE2 of 0.0004. The MAF value of CNR1
rs7766029 was 0.4806, and that of GABRA6 rs3219151 was 0.4341
in the combined population.
RESULTS
Descriptive Statistics
Mean values or frequencies of the investigated variables, and their
differences between the Budapest and Manchester subsamples
are displayed in Table 1. We can see that subjects from
Manchester are older, more depressed and more anxious, and
have experienced more stressful events related to financial and
illness/personal problems within the last year than subjects
from Budapest, moreover they also show differences in CNR1
rs7766029 genotype distribution.
Hardy–Weinberg equilibrium did not deviate from the
expected in case of either SNP (single nucleotide polymorphisms)
in the combined sample or in any of the two subsamples. For
CNR1 rs7766029 p-values were 0.967 in the combined sample,
0.337 in Budapest, and 0.402 in Manchester populations. For
GABRA6 rs3219151, 0.115 in the combined, 0.090 in Budapest,
and 0.536 in Manchester samples.
Gene-environment correlation results, calculated in additive
linear regression models, are displayed in Table 2. GABRA6
rs3219151 is significantly related to RLE-illness/personal in
Budapest, and CNR1 rs7766029 is significantly related to RLE-
social in Manchester.
Primary Analyses: Interaction Effects of
CNR1 and GABRA6 With Different Types
of Recent Stress
Table 3 displays results of the 16 primary tests and shows
that the interaction between CNR1 rs7766029 and RLE-financial
is significant both on BSI anxiety score (Figure 1) and BSI
depression score (Figure 2). However, GABRA6 rs3219151 exerts
a significant interaction with RLE-social on BSI anxiety score
(Figure 3), and with RLE-illness/personal on BSI depression
score (Figure 4).
3http://biostats.usc.edu/Quanto.html
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TABLE 1 | Description of the population samples, and differences between them.
Total sample Cohort
Budapest Manchester Comparison (p-Value)
Population size (N) 2193 902 1291
Demographics
Gender (% Male) 30.10% 29.79% 30.31% 0.792
Age (Mean ± SEM; range) 32.89 ± 0.220 31.23 ± 0.350 34.03 ± 0.279 < 0.0001
(18–60) (18–60) (18–60)
Stress type scores (within the last year)
RLE-relationship (Mean ± SEM) 0.13 ± 0.008 0.13 ± 0.013 0.14 ± 0.010 0.536
RLE-financial (Mean ± SEM) 0.23 ± 0.011 0.15 ± 0.014 0.28 ± 0.016 < 0.0001
RLE-illness/personal (Mean ± SEM) 0.37 ± 0.013 0.33 ± 0.020 0.39 ± 0.017 0.028
RLE-social (Mean ± SEM) 0.41 ± 0.013 0.41 ± 0.021 0.40 ± 0.017 0.727
Recent depression/anxiety
Current BSI depression score (Mean ± SEM) 0.87 ± 0.019 0.57 ± 0.023 1.07 ± 0.028 < 0.0001
Current BSI anxiety score (Mean ± SEM) 0.89 ± 0.019 0.70 ± 0.023 1.01 ± 0.027 < 0.0001
Genotype
CNR1 rs7766029 0.011
CC (N) 594 214 380
TC (N) 1094 466 628
TT (N) 505 222 283
MAF (minor allele) 0.48 (T) 0.50 (C) 0.46 (T)
GABRA6 rs3219151 0.791
CC (N) 434 183 251
TC (N) 1053 424 629
TT (N) 719 295 424
MAF (minor allele) 0.44 (C) 0.44 (C) 0.43 (C)
BSI, Brief Symptom Inventory; RLE, number of recent negative life events (within the last year); RLE-financial, financial difficulties; RLE-illness/personal, illness, and
personal problems; RLE-relationship, intimate relationship problems; RLE-social, social network disturbances; SEM, standard error of mean; MAF, minor allele frequency;
comparison, p-Value of the t-test or Pearson χ2 test, as appropriate. Significant p-values (< 0.05) are marked in bold.
TABLE 2 | Gene-environment correlation between CNR1 (rs7766029) and GABRA6 (rs3219151) polymorphisms and different types of recent negative life events.
CNR1 (rs7766029) GABRA6 (rs3219151)
Stress type (within the last year) β S.E. STAT P β S.E. STAT P
Combined population sample of Budapest and Manchester
RLE – relationship −0.014 0.0114 −1.185 0.236 0.003 0.0113 0.244 0.808
RLE – financial 0.019 0.0156 1.191 0.234 −0.009 0.0155 −0.594 0.552
RLE – illness/personal −0.018 0.0185 −0.973 0.331 0.004 0.0183 0.232 0.817
RLE – social −0.025 0.0190 −1.332 0.183 0.010 0.0188 0.554 0.580
Budapest subsample
RLE – relationship −0.015 0.0185 −0.819 0.413 −0.012 0.0181 −0.661 0.509
RLE – financial 0.0002 0.0205 0.011 0.991 0.004 0.0201 0.200 0.842
RLE – illness/personal −0.040 0.0289 −1.373 0.170 0.062 0.0283 2.205 0.028
RLE – social 0.028 0.0300 0.922 0.357 0.033 0.0291 1.127 0.260
Manchester subsample
RLE – relationship −0.014 0.0144 −0.951 0.342 0.009 0.0145 0.596 0.551
RLE – financial 0.029 0.0221 1.313 0.189 −0.027 0.0222 −1.231 0.219
RLE – illness/personal −0.004 0.0241 −0.172 0.864 −0.039 0.0241 −1.616 0.106
RLE – social −0.060 0.0245 −2.459 0.014 −0.004 0.0246 −0.169 0.866
S.E., standard error of beta; STAT, coefficient t-statistic; RLE, number of recent negative life events (within the last year); RLE – financial, financial difficulties;
RLE-illness/personal, recent illness and personal problems; RLE – relationship, intimate relationship problems; RLE – social, social network disturbances. We tested
additive linear regression models. The effect allele is T in case of CNR1 rs7766029, and C in case of GABRA6 rs3219151. In the combined population sample of
Budapest and Manchester there were no significant p-Values. Significant p-values (< 0.05) are marked in bold.
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TABLE 3 | Interactions of number of recent negative life events and CNR1 (rs7766029) or GABRA6 (rs3219151) polymorphisms on BSI anxiety and BSI depression
scores as the outcome in the combined Budapest + Manchester sample.
CNR1 (rs7766029) GABRA6 (rs3219151)
Stress type (within the last year) β S.E. STAT P FDR Q β S.E. STAT P FDR Q
BSI anxiety score
Interaction with RLE – relationship 0.006 0.0679 0.084 0.933 0.538 −0.045 0.0720 −0.623 0.533 0.424
Interaction with RLE – financial 0.140 0.0498 2.815 0.005 0.022 −0.077 0.0506 −1.525 0.127 0.172
Interaction with RLE – illness/personal 0.007 0.0433 0.152 0.880 0.538 −0.059 0.0423 −1.392 0.164 0.172
Interaction with RLE – social −0.007 0.0435 −0.168 0.867 0.538 −0.096 0.0415 −2.316 0.021 0.045
BSI depression score
Interaction with RLE – relationship −0.037 0.0683 −0.535 0.593 0.432 −0.100 0.0724 −1.379 0.168 0.172
Interaction with RLE – financial 0.134 0.0503 2.664 0.008 0.023 −0.057 0.0512 −1.112 0.266 0.233
Interaction with RLE – illness/personal 0.073 0.0436 1.682 0.093 0.162 −0.125 0.0426 −2.928 0.003 0.022
Interaction with RLE – social 0.001 0.0440 0.021 0.984 0.538 −0.057 0.0420 −1.349 0.177 0.172
BSI, Brief Symptom Inventory; FDR, false discovery rate; S.E., standard error of beta; STAT, coefficient t-statistic; RLE, number of recent negative life events (within the
last year); RLE – financial, financial difficulties; RLE-illness/personal, recent illness and personal problems; RLE – relationship, intimate relationship problems; RLE – social,
social network disturbances. We tested additive models on a combined population sample of Budapest and Manchester. The effect allele is T in case of CNR1 rs7766029,
and C in case of GABRA6 rs3219151. All significant P-values (marked in bold) survived correction for multiple testing (P ≤ 0.05, FDR Q ≤ 0.05).
FIGURE 1 | Significant interaction effect of financial difficulties and CNR1 rs7766029 on current anxiety scores in the total sample. Mean BSI anxiety scores are
displayed with standard error bars, in function of genotype and the number of life events related to financial difficulties occurred within the last year (general linear
model performed only for visualization purposes).
Secondary Analyses: Replicability of
Significant Results in the Two
Subsamples
Table 4 shows replicability of significant primary results within
the separate Budapest and Manchester subsamples. None of
the results proven significant in the combined sample could be
replicated in both of the subsamples. However, the interaction
of GABRA6 rs3219151 and RLE-illness/personal is significant
in Manchester and a trend in Budapest despite the differences
in subpopulation characteristics demonstrated in Table 1,
suggesting a rather generalizable effect. Nevertheless, GABRA6
rs3219151 has shown a gene-environment correlation with RLE-
illness/personal in Budapest (Table 2), albeit with the opposite
direction of effect compared to that of the GxE on BSI depression
(Tables 3, 4).
DISCUSSION
In our present study we demonstrated that variants in GABRA6
and CNR1 genes, previously implicated in both stress and
depression (Juhasz et al., 2009, 2017; Gonda et al., 2017),
interact with particular types of recent life stressors in influencing
depression and anxiety. These results suggest that different genes
and neurochemical systems may mediate the effects of different
types of recent stress. Furthermore, while stress is a significant
factor associated with both depression and anxiety, which
overlap significantly both genotypically and phenotypically, we
found that the two investigated genetic variants interacted with
different types of stress in the background of these phenotypes.
Specifically, in case of anxiety CNR1 rs7766029 showed an
interaction with recent financial stress and GABRA6 rs3219151
with recent social network-related stressors. In case of depression,
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FIGURE 2 | Significant interaction effect of financial difficulties and CNR1 rs7766029 on current depression scores in the total sample. Mean BSI depression scores
are displayed with standard error bars, in function of genotype and the number of life events related to financial difficulties occurred within the last year (general linear
model performed only for visualization purposes).
FIGURE 3 | Significant interaction effect of social network disturbances and GABRA6 rs321915 on current anxiety scores in the total sample. Mean BSI anxiety
scores are displayed with standard error bars, in function of genotype and the number of life events related to social network disturbances occurred within the last
year (general linear model performed only for visualization purposes).
CNR1 rs7766029 similarly interacted with recent financial stress,
GABRA6 rs3219151, however, interacted with recent illness and
personal problem stressors. Our findings, thus, also show that
while certain genes uniformly mediate the effect of a given
type of recent stressor in the development of various facets of
psychopathology, others may transform different stressors into
distinct phenotypes.
The Role of the Endocannabinoid
System and the CB1 Receptor in Stress,
Depression, and Anxiety
Modulation of the stress response and stress adaptation is
one of the major roles and effects of the central nervous
endocannabinoid system (Patel and Hillard, 2008). The
presynaptic CB1 endocannabinoid receptors with dense
localizations in the prefrontal cortex, amygdala and
hippocampus (Morena and Campolongo, 2014) play crucial
roles in this process (McLaughlin et al., 2014). The two
retrogradely acting endocannabinoids, anandamide (AEA)
and 2-arachidonoylglycerol (2-AG), modulate glutamate and
GABA neurons following their release and, thereby, balance
excitatory and inhibitory activity (Freund et al., 2003; Hill et al.,
2010; McLaughlin et al., 2014). CB1 activation also enhances
brainstem serotonin and noradrenaline activity and regulates the
sensitivity and activity of the hypothalamus-pituitary-adrenal
(HPA) axis in stress adaptation and habituation (Gorzalka et al.,
2008; Steiner and Wotjak, 2008; Hill et al., 2010; McLaughlin
et al., 2014). While decreased CB1 transmission contributes to
a state resembling chronic stress (Lazary et al., 2011), chronic
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FIGURE 4 | Significant interaction effect of illness/personal problems and GABRA6 rs3219151 on current depression scores in the total sample. Mean BSI
depression scores are displayed with standard error bars, in function of genotype and the number of life events related to illness, injury or problems occurred within
the last year (general linear model performed only for visualization purposes).
TABLE 4 | Re-analysis of data split according to study site in the Budapest and Manchester subsamples.
Budapest subsample Manchester subsample
Gene-environment interaction β S.E. STAT P β S.E. STAT P
BSI anxiety score
CNR1 interaction with RLE – financial 0.127 0.0794 1.601 0.110 0.143 0.0652 2.188 0.029
GABRA6 interaction with RLE – social −0.067 0.0501 −1.338 0.181 −0.111 0.0622 −1.781 0.075
BSI depression score
CNR1 interaction with RLE – financial 0.061 0.0797 0.768 0.443 0.163 0.0660 2.464 0.014
GABRA6 interaction with RLE – illness/personal −0.087 0.0514 −1.695 0.090 −0.144 0.0633 −2.280 0.023
BSI, Brief Symptom Inventory; S.E., standard error of beta; STAT, coefficient t-statistic; RLE, number of recent negative life events (within the last year); RLE – financial,
financial difficulties; RLE-illness/personal, recent illness and personal problems; RLE – social, social network disturbances. We tested replicability of the interactions in the
Budapest and Manchester subsamples. The effect allele is T in case of CNR1 rs7766029, and C in case of GABRA6 rs3219151. Significant P-values are marked in bold,
and trends are marked in italic. No correction for multiple testing was applied.
stress alters endocannabinoid transmission contributing to stress
habituation (Patel and Hillard, 2008).
The role of the endocannabinoid system and the CB1 receptor
in depression and anxiety is also supported by several lines
of animal studies linking reduced CB1 signaling to increased
depression and anxiety (Hill and Gorzalka, 2005). CB1 KO
mice showed increased sensitivity toward developing learned
helplessness, an animal model of depression, as well as anhedonia
upon exposure to chronic mild stress (Gorzalka et al., 2008),
and CB1 receptor mediated endocannabinoid transmission was
found to play a role in influencing affective processing under
stress exposure in both rodents (McLaughlin et al., 2012; Wang
et al., 2012; Morena et al., 2016) and humans (Wirz et al., 2018).
In addition, the importance of the cannabinoid signaling in
mood disorders is specifically highlighted by the severe increase
in depressive and anxiety symptoms following administration
of the CB1 antagonist appetite suppressant rimonabant in
previously non-depressed human subjects (Christensen et al.,
2008; Goodwin et al., 2012). Such studies suggest that the
endocannabinoid system buffers the emotional effects of stress
exposure (Morena and Campolongo, 2014; Morena et al., 2016),
and raise the possibility of variations in the CNR1 gene (encoding
the CB1 receptor) altering the neural information processing
of affective stimuli (Wirz et al., 2018). The endocannabinoid
system has also been reported to play a role in stress-
induced anxiety, with pharmacological or genetic disruption
of CB1 signaling increasing anxiety moderately without, and
dramatically following stress exposure (Haller et al., 2004;
Hill et al., 2011; Morena et al., 2016). Indeed, in humans
disrupted CB1 signaling related to CNR1 variation appears to
be involved in stress vulnerability and manifestation of stress
related psychiatric conditions (Morena et al., 2016) including
schizophrenia (Fernandez-Espejo et al., 2009; Gouvea et al.,
2017) as well as non-response to antipsychotics; substance
abuse and addiction (Benyamina et al., 2011; Lopez-Moreno
et al., 2012); eating disorders; autism (Hillard et al., 2012);
and mood and anxiety disorders (Ashton and Moore, 2011;
Hillard et al., 2012).
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CNR1 rs7766029 Selectively Mediates
the Effects of Financial but Not Other
Types of Recent Stress on Depression
and Anxiety Symptoms
The CNR1 gene encoding the human endocannabinoid receptor 1
(CB1) is located on chromosome 6q14-15 and while the function
of SNPs in the CNR1 gene and their effect on expression and
activity has not yet been reported, they may decrease mRNA
stability and thus contribute to reduced CB1 receptor expression
(Domschke et al., 2008). A significant association was reported
between CNR1 and high neuroticism, which leads to a propensity
to both perceive and experience life events as more negative and
stressful as well as to less adaptive coping in the face of stress
further stressing the role of this variant in the emergence of stress-
related psychopathology (Juhasz et al., 2009). CNR1 variation
increases risk and vulnerability to depression upon exposure to
both early and recent stress (Juhasz et al., 2009; Agrawal et al.,
2012). In particular, the 3′-end polymorphism rs7766029 has
been suggested to play a role in the development of depression
by impacting the experience of negative life events through
increased exposure by life choice or through response to or
interpretation of negative life events (Bouchard and Mcgue, 2003;
Juhasz et al., 2009; Aleksandrova et al., 2012) but it remained
uninvestigated whether this gene uniformly mediates the effects
of all types of stressors. Thus this is the first study to report
that CNR1 rs7766029 selectively mediates the effects of financial
stress, but not other types of recent life events in both depression
and anxiety symptoms.
Similarly to our present results, we previously reported that
in a general population sample, in males but not in females,
and in those above, but not under thirty years of age, that
the 5-HTTLPR polymorphism of the serotonin transporter gene
mediated the effects of recent financial but not other types of
stressors in the background of depression (Gonda et al., 2016a,b).
Variation in the neural nitric oxide synthase (NOS I) gene
also interacted with financial difficulty in the development of
depression in another study (Sarginson et al., 2014). In addition,
financial stress was found to predict both risk and persistence of
depression and also associated with lower remission rates during
antidepressant treatment with citalopram (Trivedi et al., 2006). It
has also been previously reported that early childhood financial
difficulties show a strong association with reduced connectivity
in the default mode network, which remains observable in
adulthood and it associated with increased stress sensitivity based
on increased cortisol production during social stress anticipation
(Sripada et al., 2014). This suggests a distinct effect of financial
problems versus other types of stressors. Financial stress can
arguably be viewed as a proxy for a threat for general safety of
existence and thus can be considered a pervasive, and especially
in extreme cases a severe and life-threatening stressor as opposed
to other, non-existential types of environmental and life events.
The importance of such stress and the vital threat linked with
it may be one reason why the effect of this type of recent
stress is mediated by multiple genes and neurochemical systems
and argues for its strong role in the background of various
manifestations of stress-related psychopathologies.
The Role of the GABA System and
GABRA6 Variation in Stress, Depression,
and Anxiety
The GABA system plays an important role in acute stress reaction
(Giordano et al., 2008) while stress exposure also exerts both short
and long-term effects on GABA signaling, including changes in
composition, sensitivity and availability of GABA-A receptors
which in turn contribute to alterations in the stress response
(Skilbeck et al., 2010; Gunn et al., 2011; Luscher et al., 2011). The
GABA system plays a key role in the HPA-axis downregulation in
response to stress as demonstrated by the strong inhibitory effect
on the HPA axis by alprazolam, an anxiolytic agent enhancing
GABA signaling by increasing the affinity of GABA for the
GABA-A receptor (Giordano et al., 2006). Studies have shown
that the GABA system in interaction with stress influences central
nervous stress control through GABA-A receptors localized
on hypothalamic CRH neurons in the paraventricular nuclei,
inhibiting the HPA axis (Oquendo and Mann, 2000; Luscher
et al., 2011) and attenuating response to stress (Gunn et al., 2011).
Chronic stress, however, leads to reduced GABA activity and thus
altered response during subsequent stress exposure (Hu et al.,
2010; Gunn et al., 2011; Luscher et al., 2011).
Disrupted GABA signaling and GABA deficit is also
hypothesized to play a role in the development of depression
and anxiety (Luscher et al., 2011), while Gad2 mRNA, the
synthesis enzyme of GABA, was upregulated after chronic
treatment with the serotonin and noradrenaline reuptake
inhibitor venlafaxine (Tamasi et al., 2015). Reciprocally, the
GABA system is also involved in regulating and fine-tuning
depression-relevant serotonergic and noradrenergic processes
(Luscher et al., 2011; Pehrson and Sanchez, 2015). Furthermore,
it appears that decreased HPA axis inhibition possibly related
to GABA-A receptor variation may in turn lead to increased
physiological stress response and higher risk of mental health
disorders like depression (Uhart et al., 2004). These results again
point to the possible involvement of GABA-A receptor variations
in the modulation of stressful stimuli in psychiatric phenotypes,
nevertheless, studies failed to investigate the roles related to
specific stressors.
GABRA6 rs3219151 Shows a Divergent
Pattern in Mediating Different Types of
Recent Stressors in the Background of
Depression and Anxiety
Rs3219151, located in the 3′ untranslated region in the GABRA6
gene encoding the alpha-6 subunit of the GABA-A receptor,
and predicted to be in the target region of 4 microRNAs,
has previously been demonstrated to play a significant role
in modulating HPA-axis activity. Those carrying the T allele
exhibited higher plasma cortisol levels both during resting
conditions (Rosmond et al., 2002) as well as during stimulation in
the Trier Social Stress Test (Uhart et al., 2004), showing that this
allele is, indeed, associated with increased stress response. Other
studies similarly reported association between GABA-A subunit
variation and stress reactivity manifested in increased blood
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pressure, cortisol, and adrenocorticotropic hormone (ACTH)
levels following stress in GABRA6 rs3219151 T allele carriers (Sen
et al., 2004; Uhart et al., 2004; Inoue et al., 2015). In a recent
study we found that while the T allele of GABRA6 rs3219151 was
not directly associated with either depression or anxiety, a strong
effect was observed in interaction with recent life stress on both
anxiety and depression (Gonda et al., 2017).
In our present study we observed that GABRA6 rs3219151
mediated the effects of different types of life events in the
background of depression and anxiety. While in case of
depression the effects of rs3219151 were observable in case of
exposure to recent illness- and personal problem related life
events, in case of anxiety rs3219151 only interacted with recent
social-network related stressors. In both cases, just as in case
of our previous study (Gonda et al., 2017), presence of the T
allele increased risk of depression and anxiety. This novel finding
corroborates previous reporting that those carrying the T allele
show a larger stress reactivity and expand these results with the
information that this increased reactivity appears to be specific to
certain life events.
In line with our previous study of 5-HTTLPR (Gonda
et al., 2016a), the present results of CNR1 rs7766029 support
a distinct role of financial stress among different life events
in the development of depression and anxiety symptoms
possibly related to the prominent and pervasive impact of
this type of stress. However, our findings concerning GABRA6
rs3219151 indicate that other types of stressors may also be
selectively mediated by distinct genetic elements, suggesting
that the effects of different types of hardships are mediated
by distinct neurochemical pathways. Furthermore, in case of
GABRA6 rs3219151 we also observed that different types of
recent stressors contribute to the emergence of different types
of psychopathology: depress ion in case of illness and personal
concerns and anxiety in case of social network-related problems.
A further interesting aspect of these results is that in case
of anxiety, a crossover pattern was observed with the “risk”
T allele associated with lower anxiety without stress exposure
and a higher anxiety in those exposed to severe stress. This
is in part similar to a previous finding of 5-HTTLPR in a
population aged younger than 30 years, we similarly found
a crossover pattern in interaction with recent social-network
related stress, however, in that case the “risk” s allele of 5-
HTTLPR was associated with decreased depression when exposed
to severe stress (Gonda et al., 2018a). Thus, our present
findings also show that the same type of stressor may increase
the risk or protect against different types of psychological
symptoms depending on the interacting gene and the involved
neurochemical system. Which, in part, may explain for the
presence of these variations in the genome and the evolutionary
maintenance of pro-depressive states.
The Importance of Investigating
the Type of Life Events in
Gene × Environment Interactions
The divergent genetic interaction patterns of distinct types
of recent stress in the background of depression and anxiety
has not been widely investigated so far, although in case of
childhood traumas the differential genetic interaction effects of
different types of maltreatment is already well-known (Cicchetti
et al., 2007; Fisher et al., 2013). Our present results clearly
show that recent stress is a heterogeneous phenomenon and
different types of recent life events and stressors may exert their
effect via different neurobiological pathways and mechanisms
in the emergence of depression and anxiety. These findings
also expand our previous results where we found that genes
belonging to different neurochemical pathways mediate the
effects of moderate or severe stress in depression, with some
genetic variants being more relevant in case of moderate and
others in case of severe recent stress exposure (Gonda et al.,
2018b). In spite of these, there is little attention paid to
subcategorization of life events according to type and severity in
genetic studies of depression, and lack of consideration of the
distinct genetic and biochemical pathways of different stressors
may be an important contributor to the lack of positive findings
and replicability in gene-environment interaction studies in
depression (Gonda et al., 2018c). Furthermore if certain genetic
variants increase risk of depression or anxiety only when exposed
to specific stressors and certain stressors only lead to depression
and anxiety in those carrying given genetic variants, this may
contribute to a more sophisticated understanding of predicting,
screening and preventing depression. Such findings may not
only advance our understanding on the complex pattern of
interaction between stressors and genes, but could also help in
the refinement of subtyping affective disorders, pinpointing new
pharmacological targets and advancing precision treatment of
these illnesses.
Limitations
There are several limitations of our present study. First of all, we
would emphasize the exploratory nature of our analyses and urge
replication of the results presented here in other cohorts. Second,
our research is cross-sectional, thus it is possible that depressive
symptoms developing with a greater latency following exposure
or repeated exposure remained hidden. Third, recent life events
occurring in the previous year were recorded retrospectively, and
these, just as measures of depression and anxiety were based
on self-report. Fourth, recall of negative life events is subject
to recall bias, which is, on the one hand memory dependent,
and on the other hand, state dependent, so it is possible that
those less depressed recalled less, while those more depressed
recalled more negative life events. Fifth, our study sample was
a general population sample of volunteers, which contributes
to a possibility of sampling bias with respect to depression.
Sixth, we used two geographically different subsamples in our
study, and ancestry was not assessed in the present study using
molecular methods such as whole-genome SNP genotyping.
Although to consider this we used population as a covariate in all
our statistical analyses, there may exist subtle genetic differences
both between the two subsamples and also within each sample
due to population stratification which may lead to spurious
effects. Finally, while our reported results were significant in
the combined population, we could not replicate some of them
separately in the two population subsamples.
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CONCLUSION
In our study we demonstrated that genetic variation in two
distinct neurochemical systems, namely, rs7766029 in the CNR1
and rs3219151 in GABRA6, mediate the effects of different types
of recent stress in depression or anxiety. Interestingly, in case
of GABRA6, the resulting psychological symptom may be the
function of the type of stress experienced. Our findings thus
show that stress is a heterogeneous phenomenon and different
types of it may activate different neural pathways. Besides its
possible clinical and pharmacological implications, our results
suggest that the environmental context of psychiatric symptoms,
disorders and relevant genes should be specified in a more
detailed and multidimensional manner in order to be able to
better predict, prevent and treat affective illnesses.
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